Characterization of a human tumorsphere glioma orthotopic model using magnetic resonance imaging.
Magnetic resonance imaging (MRI) is the imaging modality of choice by which to monitor patient gliomas and treatment effects, and has been applied to murine models of glioma. However, a major obstacle to the development of effective glioma therapeutics has been that widely used animal models of glioma have not accurately recapitulated the morphological heterogeneity and invasive nature of this very lethal human cancer. This deficiency is being alleviated somewhat as more representative models are being developed, but there is still a clear need for relevant yet practical models that are well-characterized in terms of their MRI features. Hence we sought to chronicle the MRI profile of a recently developed, comparatively straightforward human tumor stem cell (hTSC) derived glioma model in mice using conventional MRI methods. This model reproduces the salient features of gliomas in humans, including florid neoangiogenesis and aggressive invasion of normal brain. Accordingly, the variable, invasive morphology of hTSC gliomas visualized on MRI duplicated that seen in patients, and it differed considerably from the widely used U87 glioma model that does not invade normal brain. After several weeks of tumor growth the hTSC model exhibited an MRI contrast enhancing phenotype having variable intensity and an irregular shape, which mimicked the heterogeneous appearance observed with human glioma patients. The MRI findings reported here support the use of the hTSC glioma xenograft model combined with MRI, as a test platform for assessing candidate therapeutics for glioma, and for developing novel MR methods.
Division of Medical Physics, Department of Radiology, The Methodist Hospital-Weill Cornell Medical College and Center for Biotechnology and Informatics, The Methodist Hospital Research Institute, TX 77030, USA.
Kelvin
K
Wong
Geoffrey S
GS
Young
Milan
M
Makale
Xintao
X
Hu
Nalan
N
Yildirim
Kemi
K
Cui
Stephen T C
ST
Wong
Santosh
S
Kesari
D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology*; D004195:Disease Models, Animal; D005910:Glioma / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D051379:Mice; D014411:Neoplastic Stem Cells / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000473:pathology; D014183:Transplantation, Heterologous
J Neurooncol. 2008 Jun;88(2):205-10
18317691
Neoplasia. 2002 Nov-Dec;4(6):480-5
12407441
J Magn Reson Imaging. 2002 Mar;15(3):233-40
11891967
J Neurooncol. 2000 Mar;47(1):65-72
10930102
Cancer Cell. 2002 Apr;1(3):269-77
12086863
Neuron. 2007 Feb 15;53(4):503-17
17296553
Mol Cancer Res. 2008 Jan;6(1):21-30
18184972
Magn Reson Med. 1992 Sep;27(1):68-75
1435211
AJNR Am J Neuroradiol. 2000 May;21(5):891-9
10815665
Glia. 2009 Sep;57(12):1306-15
19191326
Clin Cancer Res. 2007 May 15;13(10):2897-904
17504989
Anticancer Res. 2008 Mar-Apr;28(2B):1143-50
18505050
Cancer Cell. 2006 May;9(5):391-403
16697959
Cancer J. 2003 Mar-Apr;9(2):134-45
12784879
Expert Opin Biol Ther. 2008 Apr;8(4):541-53
18352856
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12890-5
17652168
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10666-71
19541645
J Neurol Sci. 2008 Jun 15;269(1-2):180-3
18255100
Magn Reson Med. 2004 May;51(5):893-9
15122670
AJNR Am J Neuroradiol. 2001 Jan;22(1):60-4
11158889
Cancer Res. 2006 Apr 1;66(7):3355-8, discussion 3358-9
16585152
AJR Am J Roentgenol. 1998 Dec;171(6):1479-86
9843274
Neurosurgery. 2007 Feb;60(2):360-70; discussion 370-1
17290188
Histol Histopathol. 2007 Dec;22(12):1309-26
17701911
Cancer. 1997 Sep 1;80(5):936-41
9307194
Surg Neurol. 1998 Apr;49(4):436-40
9537664
Neurosurgery. 2006 Feb;58(2):365-72; discussion 365-72
16462491
Brain Pathol. 2005 Oct;15(4):342-63
16389946
DNA Cell Biol. 2007 Aug;26(8):599-601
17688411
Neurology. 2008 Mar 4;70(10):779-87
18316689
Lab Invest. 2000 Jun;80(6):837-49
10879735
J Clin Oncol. 2007 Sep 10;25(26):4127-36
17827463